Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Blagoevgrad – page 4

55 clinical trials in Blagoevgrad, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Blagoevgrad at a glance
55
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

55 trials in Blagoevgrad

Open in trial search

Endometriosis

Not recruiting

A study testing vipoglanstat for women with moderate to severe endometriosis-related pain

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:GS-248
  • Sponsor:Gesynta Pharma AB

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Asthma

Not recruiting

Study on GSK5784283 for Adults Aged 18-75 with Uncontrolled Asthma

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:GSK5784283
  • Sponsor:Glaxosmithkline Research & Development Limited

Obesity

Not recruiting

Study on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Epilepsy

Not recruiting

Study on the Effectiveness and Safety of Levetiracetam XR for Patients with Drug-Resistant Partial Onset Epilepsy

Registered drug
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Levetiracetam
  • Sponsor:Neuraxpharm Pharmaceuticals S.L.

Multiple sclerosis

Not recruiting

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cilastatin
  • Sponsor:Spero Therapeutics Inc.

Cardiac failure

Not recruiting

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Novartis Pharma AG

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Study on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Riliprubart
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Blagoevgrad

What the registry says about research in the country

01 Neurological Disorders

Research focusing on treatments for acute ischemic stroke and various forms of multiple sclerosis, including innovative therapies for both relapsing and progressive forms of MS.

  • Stroke treatment optimization
  • Multiple sclerosis management
  • Seizure control studies

Advanced clinical trials evaluating new therapeutic approaches for neurological conditions using targeted treatments and specialized medications.

02 Cardiovascular & Metabolic Conditions

Investigations into treatments for hypertriglyceridemia and various cardiovascular diseases, with studies focusing on lipid management and stroke prevention in atrial fibrillation.

  • Cardiovascular disease prevention
  • Lipid disorders
  • Weight management therapies

Comprehensive research into metabolic disorders and cardiovascular health using innovative therapeutic approaches.

03 Respiratory & Immune Disorders

Clinical studies examining treatments for asthma, COPD, and respiratory infections, alongside research into immune system disorders.

  • Asthma management
  • COPD treatment
  • RSV infection therapy

Novel therapeutic approaches targeting both acute and chronic respiratory conditions with specialized medications.

04 Chronic Conditions

Research into treatments for chronic kidney disease and related complications, including studies on anemia management and secondary hyperparathyroidism.

  • Kidney disease management
  • Anemia treatment
  • Endocrine disorders

Comprehensive evaluation of long-term therapeutic solutions for chronic conditions affecting multiple body systems.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.